We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$742M
AUM Growth
+$71.9M
Cap. Flow
+$95.5M
Cap. Flow %
12.87%
Top 10 Hldgs %
60.42%
Holding
166
New
21
Increased
99
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$23M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$18.5M
3
WPZ
Williams Partners L.P.
WPZ
+$12.3M
4
BPL
Buckeye Partners, L.P.
BPL
+$9.48M
5
EPD icon
Enterprise Products Partners
EPD
+$8.44M

Top Sells

Rank Stock Value
1
OKS
Oneok Partners LP
OKS
+$34.2M
2
PAA icon
Plains All American Pipeline
PAA
+$1.69M
3
CEQP
Crestwood Equity Partners LP
CEQP
+$1.62M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$1.55M
5
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.4M

Sector Composition

Rank Sector Weight
1 Energy 73.54%
2 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
51
Ligand Pharmaceuticals
LGND
$6.02B
$1.22M 0.16%
14,342
– –
MNTA
52
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.19M 0.16%
64,489
– –
FAS icon
53
Direxion Daily Financial Bull 3x ETF
FAS
$2.38B
$1.15M 0.15%
+20,503
New +$1.06M
KERX
54
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.11M 0.15%
157,065
– –
PGNX
55
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.1M 0.15%
148,929
– –
BMRN icon
56
BioMarin Pharmaceuticals
BMRN
$11.4B
$1.05M 0.14%
11,260
– –
IONS icon
57
Ionis Pharmaceuticals
IONS
$9.41B
$1.03M 0.14%
20,375
– –
OMER icon
58
Omeros
OMER
$719M
$1.02M 0.14%
47,112
– –
INCY icon
59
Incyte
INCY
$23.6B
$1.01M 0.14%
8,619
– –
MDCO
60
DELISTED
Medicines Co
MDCO
$1M 0.14%
27,060
– –
SEP
61
DELISTED
Spectra Engy Parters Lp
SEP
$993K 0.13%
22,367
+4,166
+23% +$185K
REGN icon
62
Regeneron Pharmaceuticals
REGN
$69.4B
$971K 0.13%
2,171
– –
RDUS
63
DELISTED
Radius Health, Inc.
RDUS
$960K 0.13%
24,899
– –
TBPH icon
64
Theravance Biopharma
TBPH
$874M
$947K 0.13%
27,646
– –
UTHR icon
65
United Therapeutics
UTHR
$26.4B
$932K 0.13%
7,952
– –
IRWD icon
66
Ironwood Pharmaceuticals
IRWD
$624M
$920K 0.12%
69,665
– –
TSRO
67
DELISTED
TESARO, Inc.
TSRO
$916K 0.12%
7,097
– –
SGEN
68
DELISTED
Seagen Inc. Common Stock
SGEN
$881K 0.12%
16,188
– –
GDX icon
69
VanEck Gold Miners ETF
GDX
$23.1B
$853K 0.12%
+37,167
New +$858K
ONC
70
BeOne Medicines Ltd
ONC
$33.8B
$839K 0.11%
8,113
+560
+7% +$41.7K
SGYP
71
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$716K 0.1%
247,030
– –
DVAX
72
DELISTED
Dynavax Technologies
DVAX
$673K 0.09%
31,321
-6,856
-18% -$108K
SGMO
73
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$660K 0.09%
43,982
+4,023
+10% +$44.5K
INSM icon
74
Insmed
INSM
$23.1B
$649K 0.09%
20,798
+1,902
+10% +$36.2K
VNQ icon
75
Vanguard Real Estate ETF
VNQ
$40B
$641K 0.09%
7,711
+1,985
+35% +$166K
1 2
3
4 5

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Virtus ETF Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Virtus ETF Advisers held 166 positions worth $742M, up 11% from $670M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Virtus ETF Advisers deployed $95.5M of net new capital in Q3 2017, opening 21 new positions and adding to 99 existing holdings. Its largest new stake was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.

By sector, the portfolio is most concentrated in Energy at 74% of assets, down from 74% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Plains All American Pipeline, an estimated $1.69M trimmed.

  • Virtus ETF Advisers's largest Q3 2017 buy was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2017, an estimated $23M increase.
  • Virtus ETF Advisers's biggest Q3 2017 reduction was Plains All American Pipeline, cutting an estimated $1.69M.
  • Virtus ETF Advisers fully exited Oneok Partners LP in Q3 2017, selling an estimated $34.2M.
  • Virtus ETF Advisers's ten largest holdings make up 60% of its $742M portfolio in Q3 2017.
  • Virtus ETF Advisers opened 21 new positions and closed 7 in Q3 2017.
  • Virtus ETF Advisers's portfolio value rose 11% quarter-over-quarter to $742M.

Based on Virtus ETF Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.